Pharmacokinetics & Pharmacodynamics

ANEWCRO provides both naïve and non-naïve colonies of cynomolgus non-human primates to support pharmacokinetic (PK) and pharmacodynamic (PD) studies, offering researchers a reliable and well-characterized model for evaluating drug behavior, metabolism, and bioavailability.

​

Our colonies are maintained under stringent care and regulatory compliance, ensuring high-quality data generation for preclinical and translational research. Whether you require subjects with no prior exposure to experimental compounds or those with specific study histories, our facility can accommodate diverse research needs.

​

For sponsors seeking dedicated study cohorts, we offer the option of client-exclusive colonies, providing full control over study design, animal selection, and data collection. This ensures consistency and reproducibility in long-term research projects, optimizing study outcomes.

​

Recognizing the critical interplay between PK and PD parameters, our multidisciplinary team collaborates closely with clients to design studies that elucidate the dynamic relationship between drug exposure and therapeutic effect. This integrated strategy not only optimizes dosing regimens but also enhances the translational potential of preclinical data, accelerating the journey from discovery to clinical application.

​

Whether you are investigating small molecules, biologics, or novel drug delivery systems, our PK/PD solutions are tailored to meet the specific demands of your research, ensuring robust and reproducible results.

​

Partner with ANEWCRO to leverage our cutting-edge pharmacokinetics and pharmacodynamics expertise. Our commitment to quality, innovation, and regulatory compliance ensures that your preclinical studies are conducted to the highest standards, paving the way for successful clinical translation and groundbreaking therapeutic advancements.